RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+8.07%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$871M
AUM Growth
+$871M
(+6.9%)
Cap. Flow
+$108M
Cap. Flow
% of AUM
12.44%
Top 10 Holdings %
Top 10 Hldgs %
80.56%
Holding
31
New
7
Increased
6
Reduced
3
Closed
9
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$61.2M |
| 2 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$46.8M |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
$31M |
| 4 |
RDUS
Radius Health, Inc.
RDUS
|
$22.5M |
| 5 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$18.7M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$25.9M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$14.2M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$12.6M |
| 4 |
Neurogene
NGNE
|
$11.1M |
| 5 |
Ardelyx
ARDX
|
$10.5M |
Sector Composition
| 1 | Healthcare | 96.54% |